The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 |
|---|---|
| Net income | 510,262 |
| Payment of operation costs through promissory note | 2,491 |
| Interest earned on cash and investments held in trust accounts | 761,174 |
| Prepaid expenses and insurance | 55,288 |
| Long-term prepaid insurance | 54,886 |
| Accounts payable and accrued expenses | 24,176 |
| Deferred consulting fees | 60,000 |
| Net cash used in operating activities | -274,419 |
| Investment of cash in trust accounts | 230,000,000 |
| Net cash used in investing activities | -230,000,000 |
| Proceeds from sale of units, net of underwriting discounts paid | 226,895,000 |
| Proceeds from sale of private placement units | 4,955,000 |
| Underwriters' reimbursement | 250,000 |
| Repayment of promissory note - related party | 264,083 |
| Payment of offering costs | 612,097 |
| Net cash provided by financing activities | 231,223,820 |
| Net change in cash | 949,401 |
| Cash - beginning of period | 0 |
| Cash - end of period | 949,401 |
Cambridge Acquisition Corp. (CAQUW)
Cambridge Acquisition Corp. (CAQUW)